drugset / Trial / NCT06145607
A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262
NaSingle-groupOpen-labelTreatment
Summary
This study is a randomized, three period, six sequence, single dose crossover design with ABBV-CLS-7262 in healthy adult subjects.
Timeline
- Start
- 2023-12-19
- Primary completion
- 2024-01-30
- Completion
- 2024-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-CLS-7262 | Unknown | — | — |
Indications
No indication recorded.